Biologic Contract Manufacturing WebinarPosted on May 28, 2024 |
 |
June 6, 2024, 10:00 a.m. – 12:00 p.m. EST
Michael Hausladen, PhD, General Manager,
LOTTE Biologics
Register in advance for this meeting here.
After registering, you will receive a confirmation email.
Michael Hausladen is the General Manager for LOTTE Biologics USA, LLC, headquartered in Syracuse, NY. LOTTE Biologics is a Contract Development and Manufacturing Organization that is serving the biologic pharmaceutical market. Previous roles at Bristol Myers Squibb (BMS) included starting up the Devens, MA $350M Cell Therapy Facility, managing clinical external biologics manufacturing and various leadership roles including Director of Manufacturing and Director of Manufacturing Technology.
Prior to working in biologics, Michael worked at BMS scaling up and commercialization of enzyme catalyzed and traditional organic synthesis of active pharmaceutical ingredients. Michael has a PhD in chemical engineering from the University at Buffalo.
Other Member News
May 20, 2026Give Now, Decide Later: A Smarter Way to Approach Charitable Giving for High-Income EarnersWith tax season wrapped up and continued conversations locally around nonprofit sustainability and community giving, this piece offers a fresh, practical perspective for community members looking to make a meaningful impact. |
May 19, 2026NBT Bank Recognized with 2025 Cigna Healthy Workforce Designation™Cigna Healthcare® has selected NBT Bank as a recipient of its 2025 gold level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and vitality of its employees through a workplace well-being program. |
May 18, 2026Casino Player Magazine Awards Turning Stone Resort Casino “2026 Best Overall Dining” in New York StateThe 2026 Casino Player Magazine “Best of Dining & Nightlife Awards” recognizes the best establishments in the entire casino industry. Voted on by guests and readers, Turning Stone recognized as the top property in New York in 12… |
